Heparin Sodium Injection · #9 of 35 active shortages by FDA posting duration
Brand: HEPARIN SODIUM
FDA lists Heparin Sodium Injection as Active Shortage (Fresenius Kabi USA, LLC).
Availability on file: Available
Heparin Sodium Injection: Active Shortage
Available 10 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Heparin Sodium Injection
- Manufacturer
- Fresenius Kabi USA, LLC
- Dosage Form
- Injection
- Presentation
- Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-77)
- Package NDC
- 63323-519-77
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Nov 14, 2017
- Last Updated
- Mar 17, 2026
- Therapeutic Category
- Hematology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Check wholesalers for inventory
Full Drug Profile
heparin
Side effects, interactions, warnings & more
Nearby, Other Heparin Shortage Records
Heparin Sodium Injection
Hospira, Inc., a Pfizer Company
Injection
Heparin Sodium Injection
Hospira, Inc., a Pfizer Company
Injection
Heparin Sodium Injection
Baxter Healthcare
Injection
Heparin Sodium Injection
Baxter Healthcare
Injection
Heparin Sodium Injection
Baxter Healthcare
Injection
Heparin Sodium Injection
B. Braun Medical Inc.
Injection
FDA reason on file: Check wholesalers for inventory. General shortage guidance lives on the tracker hub.